29.05.2020 BE law Stibbe assists Avista Capital Partners Experience - Stibbe assisted Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare. Read more Team: Dries Hommez, Hans Witteveen, Wouter Ghijsels, Michael Molenaars, Henk Verstraete, Pieter-Jan Leemen, Margaux Beyer, Sebastiaan Witkam, Britt Vanderschrick, Nina Coussement, Esther Everaert
24.04.2020 BE law Stibbe assists LDA Capital Experience - Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Read more Team: Jan Peeters, Liselot Claeys
06.11.2019 NL law Stibbe advises Wright Medical Group Experience - Stibbe is advising Wright Medical Group on the offer from Stryker to acquire Wright Medical Group. Read more Team: Duco de Boer, Jeroen Smits, Eva Das, Manon Cremers, Pieter Schütte, Dennis Mollema, Tom Storck, Claire-Marie Darnand
26.06.2019 BE law Stibbe advises DW Healthcare Partners Experience - Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Read more Team: Gérald Origer, Julien Bogaerts, Jérôme Aubertin, Jean-Marc Delcour, Michaël Meylan, Steven Paridaens, Joanna De Smedt, Giada Mognol
14.12.2018 NL law Stibbe advises Aedifica Experience - Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland). Read more Team: Maarten de Bruin, Boris Cammelbeeck, Jan van Oosten, Ashley Peeters, Eloïse Spoelman, Jake Tingen
08.10.2018 NL law Stibbe advises Aedifica Experience - Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Read more Team: Maarten de Bruin, Edsart van Wulfften Palthe
10.09.2018 NL law Stibbe advises on the equity offering of ProQR Experience - Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). Read more Team: Pieter Schütte, Jeroen Smits, Lotte Hover-Boon, Emilie Renardel de Lavalette
26.07.2018 NL law Stibbe advises Agendia Experience - Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management. Read more Team: Pieter Schütte, Rein van Helden, Manon Cremers, Fons Leijten, Suzanne van Boheemen, Eline Holtman, Rik van Kessel, Emilie Renardel de Lavalette
12.04.2018 NL law Stibbe advises SleepScore Labs Experience - Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company. Read more Team: Heleen Kersten, Reinout de Boer, Ea Visser
29.03.2018 NL law Stibbe advises Lundbeck Experience - Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million. Read more Dennis Mollema Senior Associate Amsterdam
08.03.2018 NL law Stibbe advises Canon Medical Systems Experience - Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon. Read more Team: Reinout de Boer, Sophie Zwartkruis-Bakker, Dennis Mollema, Boris Cammelbeeck, Ea Visser
15.11.2017 NL law Stibbe advises Aedifica Experience - Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist). Read more Team: Maarten de Bruin, Jan van Oosten
23.08.2021 NL law Proposed Amendments to the Dutch Tax Treatment of Stock Option Plans Articles - Recent efforts by the Dutch government to amend the tax treatment of stock option plans are examined by Charlotte Tolman and Michael Molenaars in this article in Tax Notes International. The proposed changes are welcome, but might not solve all liquidity concerns. Read more Team: Michael Molenaars, Charlotte Tolman
28.07.2021 NL law Draft bill on Expedited Liquidation Transparency presented Short Reads - The draft temporary bill on Expedited Liquidation Transparency presented by the Dutch Minister of Justice on 28 June 2021 aims to increase transparency, improve protection of creditors and reduce the risk of abuse. We expect that this bill could be in effect indefinitely, as the issues it addresses were pressing long before COVID-19. Read more Team: Sophie Beerepoot, Bram Berends
03.11.2020 BE law Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Articles - Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. Read more Team: Philippe Campolini, Ignace Vernimme, Peter Wytinck, Sophie Van Besien
30.03.2020 BE law Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures Short Reads - The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types. Read more Team: Jan Bouckaert, Bastiaan Schelstraete, Maarten Christiaens
29.07.2021 NL law Tackling Reverse-Hybrid and Entity Classification Mismatches In the Netherlands Articles - This article, published in Tax Notes International, examines two recent Dutch proposals, which could have an immediate impact on Dutch and non-Dutch corporate taxpayers and existing national or international structures. Read more Team: Michael Molenaars, Charlotte Tolman
18.06.2021 NL law FAQ: Wat houdt het Wetsvoorstel elektronische gegevensuitwisseling in de zorg (Wegiz) in en wat is de verhouding tot de AVG? Short Reads - (Digitale) gegevensuitwisseling in de zorg is een actueel thema. Illustratief is een item bij EenVandaag van april 2021 waarin de analoge werkwijze bij gegevensuitwisseling in de zorg wordt aangekaart, maar ook dit artikel in het NRC van afgelopen maand waarin verslag werd gedaan van een datalek waardoor duizenden gevoelige patiëntgegevens op straat kwamen te liggen. Read more Team: Tom Barkhuysen, Sophie Ravelli, Steven Bastiaans
25.09.2020 BE law Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Articles - Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin. Read more Team: Ignace Vernimme, Philippe Campolini
23.03.2020 BE law Contracts & Corona: force majeure and related topics Short Reads - The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions. Read more Team: Oliver Stevens, Tobe Inghelbrecht
28.07.2021 NL law Veiligheid gaat voor alles: drie redenen voor een actuele RI&E Short Reads - Een risico-inventarisatie en -evaluatie met bijbehorend plan is verplicht voor iedere werkgever, maar veel werkgevers hebben deze niet. In dit blog gaan we in op de inhoud en achtergrond van de RI&E en op de risico's voor werkgevers die geen RI&E hebben. Read more Team: Lisa van der Maden, Monique van der Linden, Imran Hyder
18.02.2021 BE law Philippe Campolini is a panelist during a webinar organised by EPLAW Seminar - Philippe Campolini, partner in our IP department and board member of EPLAW (the European Patent Lawyers Association), is panelist during a webinar on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Read more Philippe Campolini Partner Brussels
14.07.2020 EU law Breaking news from the CJEU: no SPCs for new therapeutic applications Short Reads - On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products. Read more Team: Philippe Campolini, Ignace Vernimme, Manuel Campolini, Louis Bidaine
11.03.2020 NL law Jeroen Kortmann nominated for best Dutch litigator Inside Stibbe - For the second consecutive year, Jeroen Kortmann has been nominated for the title of 'best Dutch litigator'. Read more Jeroen Kortmann Partner Amsterdam